News

Though popular weight loss jabs like Ozempic and Wegovy have been deemed safe and effective by the FDA, concerning side ...
Of the total ER visits, nearly 70% involved GI issues, 15% of which led to hospitalization, according to a new study.
Study participants were randomly assigned 2:1 to receive oral semaglutide 25mg (n=205) or placebo (n=102), as an adjunct to lifestyle intervention. The coprimary endpoints were the relative change in ...
An analysis of emergency visits related to the active ingredient in drugs like Ozempic and Wegovy have exposed a surprising ...
Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...
Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic ...
The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new study published Wednesday.
A decision is expected in the fourth quarter of 2025.
A new study analyzed how often people develop severe side effects after taking semaglutide β€” known by brand names Ozempic and ...